XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.23.1

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022
--- | --- | ---
Investments at cost | $ 724,162 | $ 721,248
Investments at fair value | 715,312 | 720,026
Investment, Unaffiliated Issuer [Member] |  |
Investments at cost | 724,162 | 721,248
Investments at fair value | 714,466 | 720,026
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |
Principal Amount |  |
Investments at cost | 703,781 | 701,074
Investments at fair value | 684,554 | 686,458
Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost | 14,735 | 14,790
Investments at fair value | 25,658 | 29,712
Investment, Unaffiliated Issuer [Member] | Other Long-Term Investments [Member] |  |
Investments at cost | 1,200 | 1,200
Investments at fair value | 1,300 | 1,300
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |
Investments at cost | 4,446 | 4,184
Investments at fair value | 2,954 | 2,556
Investment, Affiliated Issuer, Noncontrolled [Member] |  |
Investments at cost | 0 | 0
Investments at fair value | 846 | 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] |  |
Investments at cost | 0 |
Investments at fair value | 846 |
Biotechnology Sector [Member] |  |
Investments at cost | 187,970 | 193,372
Investments at fair value | 186,981 | 195,006
Medical Device Sector [Member] |  |
Investments at cost | 129,102 | 132,803
Investments at fair value | 131,823 | 135,960
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost | 4,158 |
Investments at fair value | 6,603 |
Software Sector [Member] |  |
Investments at cost | 145,706 | 120,157
Investments at fair value | 143,680 | 118,716
Diagnostics Sector [Member] |  |
Investments at cost | 9,862 | 9,851
Investments at fair value | 9,868 | 9,858
Communications Sector [Member] |  |
Investments at cost | 22,913 | 22,892
Investments at fair value | 26,168 | 26,176
Other Healthcare Sector [Member] |  |
Investments at cost | 6,990 | 7,559
Investments at fair value | 1,414 | 3,870
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |
Investments at cost | 309,108 | 318,172
Investments at fair value | 307,749 | 317,568
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost |  | 4,197
Investments at fair value |  | $ 9,792
Number of shares (in shares) |  |
Other Sustainability Sector [Member] |  |
Investments at cost | 84,753 | $ 84,633
Investments at fair value | 83,734 | 85,524
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost | 922 |
Investments at fair value | 739 |
Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |
Investments at cost | 32,926 | 30,729
Investments at fair value | 26,137 | 25,819
Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost | 424 | 416
Investments at fair value | 1,945 | 1,953
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |
Investments at cost | 277,916 | 268,468
Investments at fair value | 267,673 | 259,366
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost | 9,231 | 9,249
Investments at fair value | $ 16,371 | 16,148
Number of shares (in shares) |  |
Data Storage Sector [Member] |  |
Investments at cost | $ 476 | 476
Investments at fair value | 1,302 | 1,316
Internet and Media Sector [Member] |  |
Investments at cost | 329 | 329
Investments at fair value | 1,583 | 1,159
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |
Investments at cost | 83,831 | 83,705
Investments at fair value | 82,995 | 83,705
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost |  | 928
Investments at fair value |  | $ 1,819
Number of shares (in shares) |  |
Networking Sector [Member] |  |
Investments at cost | 10,111 | $ 11,831
Investments at fair value | 9,984 | 11,710
Power Management Sector [Member] |  |
Investments at cost | 1,585 | 1,585
Investments at fair value | 2,808 | 2,610
Semiconductor Sector [Member] |  |
Investments at cost | 57 | 56
Investments at fair value | 0 | 0
Software, Healthcare Information and Service [Member] |  |
Investments at cost | 16,498 | 13,735
Investments at fair value | $ 16,800 | $ 14,044
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Jan. 01, 2025 | Jan. 01, 2025
Principal Amount | $ 2,913 | $ 2,885
Investments at cost | 2,860 | 2,853
Investments at fair value | $ 2,779 | $ 2,777
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Jan. 01, 2025 | Jan. 01, 2025
Principal Amount | $ 2,885 | $ 2,885
Investments at cost | 2,832 | 2,823
Investments at fair value | 2,752 | 2,750
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 311 | 311
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 26,444 | 26,442
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Jan. 01, 2025 | Jan. 01, 2025
Principal Amount | $ 1,442 | $ 1,442
Investments at cost | 1,416 | 1,411
Investments at fair value | $ 1,375 | $ 1,374
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Feb. 01, 2025 | Feb. 01, 2025
Principal Amount | $ 2,885 | $ 2,885
Investments at cost | 2,829 | 2,821
Investments at fair value | $ 2,749 | $ 2,748
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Feb. 01, 2025 | Feb. 01, 2025
Principal Amount | $ 2,885 | $ 2,885
Investments at cost | 2,829 | 2,821
Investments at fair value | $ 2,749 | $ 2,748
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Apr. 01, 2025 | Apr. 01, 2025
Principal Amount | $ 1,442 | $ 1,442
Investments at cost | 1,412 | 1,408
Investments at fair value | $ 1,370 | $ 1,371
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Apr. 01, 2025 | Apr. 01, 2025
Principal Amount | $ 1,442 | $ 1,442
Investments at cost | 1,412 | 1,408
Investments at fair value | $ 1,370 | $ 1,371
Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 8.75% | 8.75%
Ceiling | 0.00% | 0.00%
ETP | 6.00% | 6.00%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,922 | 4,914
Investments at fair value | $ 4,922 | $ 4,914
Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 8.75% | 8.75%
Ceiling | 0.00% | 0.00%
ETP | 6.00% | 6.00%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,461 | 2,457
Investments at fair value | 2,461 | 2,457
Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 264 | 264
Investments at fair value | $ 28 | $ 37
Number of shares (in shares) | 318,181 | 318,181
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.00% | 12.25%
Margin | 5.25% | 5.25%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 3,500 | $ 3,500
Investments at cost | 3,457 | 3,349
Investments at fair value | $ 3,457 | $ 3,349
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.00% | 12.25%
Margin | 5.25% | 5.25%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 3,500 | $ 3,500
Investments at cost | 3,457 | 3,454
Investments at fair value | 3,457 | 3,454
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 71 | 71
Investments at fair value | $ 81 | $ 83
Number of shares (in shares) | 135,484 | 135,484
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.25% |
Margin | 5.25% |
Floor | 9.00% |
Ceiling | 0.00% |
ETP | 5.00% |
Maturity Date | Jul. 01, 2027 |
Principal Amount | $ 3,500 |
Investments at cost | 3,447 |
Investments at fair value | $ 3,447 |
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 13.25% |
Margin | 5.25% |
Floor | 9.00% |
Ceiling | 0.00% |
ETP | 5.00% |
Maturity Date | Jul. 01, 2027 |
Principal Amount | $ 3,500 |
Investments at cost | 3,447 |
Investments at fair value | $ 3,447 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 11.25% | 11.25%
Margin | 6.00% | 6.00%
Floor | 9.50% | 9.50%
Ceiling | 11.25% | 11.25%
ETP | 3.00% | 3.00%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,520 | 3,478
Investments at fair value | $ 3,520 | $ 3,478
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 11.25% | 11.25%
Margin | 6.00% | 6.00%
Floor | 9.50% | 9.50%
Ceiling | 11.25% | 11.25%
ETP | 3.00% | 3.00%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 1,250 | $ 1,250
Investments at cost | 1,239 | 1,238
Investments at fair value | 1,239 | 1,238
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 70 | 56
Investments at fair value | $ 237 | $ 233
Number of shares (in shares) | 33,742 | 31,966
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 11.25% | 11.25%
Margin | 6.00% | 6.00%
Floor | 9.50% | 9.50%
Ceiling | 11.25% | 11.25%
ETP | 3.00% | 3.00%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,717 | 3,715
Investments at fair value | $ 3,717 | $ 3,715
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 11.25% | 11.25%
Margin | 6.00% | 6.00%
Floor | 9.50% | 9.50%
Ceiling | 11.25% | 11.25%
ETP | 3.00% | 3.00%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 1,250 | $ 1,250
Investments at cost | 1,239 | 1,238
Investments at fair value | $ 1,239 | $ 1,238
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 11.25% | 11.25%
Margin | 6.00% | 6.00%
Floor | 9.50% | 9.50%
Ceiling | 11.25% | 11.25%
ETP | 3.00% | 3.00%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,717 | 3,715
Investments at fair value | $ 3,717 | $ 3,715
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |
Cash Rate | 11.25% | 11.25%
Margin | 6.00% | 6.00%
Floor | 9.50% | 9.50%
Ceiling | 11.25% | 11.25%
ETP | 3.00% | 3.00%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 1,250 | $ 1,250
Investments at cost | 1,239 | 1,238
Investments at fair value | $ 1,239 | $ 1,238
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |
Cash Rate | 11.25% | 11.25%
Margin | 6.00% | 6.00%
Floor | 9.50% | 9.50%
Ceiling | 11.25% | 11.25%
ETP | 3.00% | 3.00%
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,701 | 3,698
Investments at fair value | $ 3,701 | $ 3,698
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] |  |
Cash Rate | 11.25% | 11.25%
Margin | 6.00% | 6.00%
Floor | 9.50% | 9.50%
Ceiling | 11.25% | 11.25%
ETP | 3.00% | 3.00%
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,701 | 3,698
Investments at fair value | $ 3,701 | $ 3,698
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Nine [Member] |  |
Cash Rate | 11.25% |
Margin | 6.00% |
Floor | 9.50% |
Ceiling | 11.25% |
ETP | 3.00% |
Maturity Date | Apr. 01, 2028 |
Principal Amount | $ 3,750 |
Investments at cost | 3,698 |
Investments at fair value | $ 3,698 |
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.50% | 14.00%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 3.50% | 3.50%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 6,500 | $ 6,500
Investments at cost | 6,359 | 6,347
Investments at fair value | $ 6,359 | $ 6,347
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.50% | 14.00%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 3.50% | 3.50%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 6,000 | $ 6,000
Investments at cost | 5,869 | 5,859
Investments at fair value | 5,869 | 5,859
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 455 | 455
Investments at fair value | $ 196 | $ 197
Number of shares (in shares) | 516,732 | 516,732
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.50% | 14.00%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 3.50% | 3.50%
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,442 | 2,436
Investments at fair value | $ 2,442 | $ 2,436
Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.00% | 12.25%
Margin | 5.25% | 5.25%
Floor | 8.50% | 8.50%
Ceiling | 0.00% | 0.00%
ETP | 20.00% | 20.00%
Maturity Date | Jun. 30, 2023 | Sep. 15, 2022
Principal Amount | $ 2,528 | $ 2,500
Investments at cost | 2,528 | 2,500
Investments at fair value | $ 2,528 | $ 2,500
Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.00% | 12.25%
Margin | 5.25% | 5.25%
Floor | 8.50% | 8.50%
Ceiling | 0.00% | 0.00%
ETP | 20.00% | 20.00%
Maturity Date | Jun. 30, 2023 | Sep. 15, 2022
Principal Amount | $ 2,528 | $ 2,500
Investments at cost | 2,528 | 2,500
Investments at fair value | $ 2,528 | $ 2,500
Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.00% |
Margin | 5.25% |
Floor | 8.50% |
Ceiling | 0.00% |
ETP | 50.00% |
Maturity Date | Jun. 30, 2023 |
Principal Amount | $ 200 |
Investments at cost | 200 |
Investments at fair value | $ 200 |
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 12.75% | 12.00%
Margin | 5.00% | 5.00%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Mar. 01, 2025 | Mar. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,946 | 4,939
Investments at fair value | $ 4,946 | $ 4,939
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 12.75% | 12.00%
Margin | 5.00% | 5.00%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Mar. 01, 2025 | Mar. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,946 | 4,939
Investments at fair value | 4,946 | 4,939
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 194 | 194
Investments at fair value | $ 379 | $ 385
Number of shares (in shares) | 809,931 | 809,931
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 12.75% | 12.00%
Margin | 5.00% | 5.00%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Mar. 01, 2025 | Mar. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,940 | 4,933
Investments at fair value | $ 4,940 | $ 4,933
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 12.75% | 12.00%
Margin | 5.00% | 5.00%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Mar. 01, 2025 | Mar. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,941 | 4,933
Investments at fair value | $ 4,941 | $ 4,933
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 12.75% | 12.50%
Margin | 5.00% | 5.00%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,920 | 4,913
Investments at fair value | $ 4,920 | $ 4,913
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |
Cash Rate | 12.75% | 12.50%
Margin | 5.00% | 5.00%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,920 | 4,913
Investments at fair value | $ 4,920 | $ 4,913
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.00% | 13.50%
Margin | 6.00% | 6.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 3.50% | 3.50%
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,388 | 2,385
Investments at fair value | $ 2,388 | $ 2,385
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.00% | 13.50%
Margin | 6.00% | 6.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 3.50% | 3.50%
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,476 | 2,473
Investments at fair value | 2,476 | 2,473
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 47 | 47
Investments at fair value | $ 53 | $ 54
Number of shares (in shares) | 159,893 | 159,893
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.00% | 13.50%
Margin | 6.00% | 6.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 3.50% | 3.50%
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,951 | 4,946
Investments at fair value | $ 4,951 | $ 4,946
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.75% | 13.00%
Margin | 6.00% | 6.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026
Principal Amount | $ 7,500 | $ 7,500
Investments at cost | 7,459 | 7,455
Investments at fair value | $ 7,459 | $ 7,455
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.75% | 13.00%
Margin | 6.00% | 6.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026
Principal Amount | $ 7,500 | $ 7,500
Investments at cost | 7,459 | 7,455
Investments at fair value | 7,459 | 7,455
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 46 | 46
Investments at fair value | $ 64 | $ 67
Number of shares (in shares) | 1,991 | 1,991
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.75% | 13.00%
Margin | 6.00% | 6.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026
Principal Amount | $ 7,500 | $ 7,500
Investments at cost | 7,459 | 7,455
Investments at fair value | 7,459 | $ 7,455
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Convertible Debt Securities [Member] |  |
Cash Rate |  | 3.00%
Maturity Date |  | Jul. 01, 2023
Principal Amount |  | $ 250
Investments at cost |  | 250
Investments at fair value |  | $ 306
Axiom Space, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] |  |
Investments at cost | 261 |
Investments at fair value | $ 306 |
Number of shares (in shares) | 1,810 |
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 6.00% | 6.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,467 | 2,463
Investments at fair value | $ 2,361 | $ 2,364
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 6.00% | 6.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,467 | 2,463
Investments at fair value | 2,361 | 2,364
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 48 | 48
Investments at fair value | $ 31 | $ 31
Number of shares (in shares) | 27,330 | 27,330
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 12.88% | 12.50%
Margin | 6.05% | 6.05%
Floor | 9.55% | 9.55%
Ceiling | 13.50% | 13.50%
ETP | 5.50% | 5.50%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,895 | 4,891
Investments at fair value | $ 4,895 | $ 4,891
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 12.88% | 12.50%
Margin | 6.05% | 6.05%
Floor | 9.55% | 9.55%
Ceiling | 13.50% | 13.50%
ETP | 5.50% | 5.50%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,967 | 4,963
Investments at fair value | 4,967 | 4,963
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 214 | 214
Investments at fair value | $ 329 | $ 335
Number of shares (in shares) | 7,404 | 7,404
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 12.88% | 12.50%
Margin | 6.05% | 6.05%
Floor | 9.55% | 9.55%
Ceiling | 13.50% | 13.50%
ETP | 5.50% | 5.50%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 3,000 | $ 3,000
Investments at cost | 2,977 | 2,978
Investments at fair value | $ 2,977 | $ 2,978
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 12.88% | 12.50%
Margin | 6.05% | 6.05%
Floor | 9.55% | 9.55%
Ceiling | 13.50% | 13.50%
ETP | 5.50% | 5.50%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,967 | 4,963
Investments at fair value | $ 4,967 | $ 4,963
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 12.88% | 12.50%
Margin | 6.05% | 6.05%
Floor | 9.55% | 9.55%
Ceiling | 13.50% | 13.50%
ETP | 5.50% | 5.50%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,970 | 4,963
Investments at fair value | $ 4,970 | $ 4,963
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |
Cash Rate | 12.88% | 12.50%
Margin | 6.05% | 6.05%
Floor | 9.55% | 9.55%
Ceiling | 13.50% | 13.50%
ETP | 5.50% | 5.50%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 3,000 | $ 3,000
Investments at cost | 2,980 | 2,978
Investments at fair value | 2,980 | 2,978
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |
Investments at cost | 250 | 250
Investments at fair value | $ 250 | $ 250
Number of shares (in shares) | 1,162 | 1,162
Meditrina, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 83 | $ 83
Investments at fair value | $ 98 | $ 101
Number of shares (in shares) | 233,993 | 233,993
Kate Farms, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 102 | $ 102
Investments at fair value | $ 1,363 | $ 1,370
Number of shares (in shares) | 82,965 | 82,965
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 153 | $ 153
Investments at fair value | $ 148 | $ 150
Number of shares (in shares) | 1,375,727 | 1,375,727
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, One [Member] |  |
Cash Rate | 12.87% | 12.37%
Margin | 8.20% | 8.20%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jan. 01, 2024 | Jan. 01, 2024
Principal Amount | $ 1,250 | $ 1,625
Investments at cost | 1,239 | 1,610
Investments at fair value | $ 1,239 | $ 1,610
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Two [Member] |  |
Cash Rate | 12.87% | 12.37%
Margin | 8.20% | 8.20%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jan. 01, 2024 | Jan. 01, 2024
Principal Amount | $ 83 | $ 108
Investments at cost | 83 | 107
Investments at fair value | $ 83 | $ 107
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Three [Member] |  |
Cash Rate | 12.87% | 12.37%
Margin | 8.20% | 8.20%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Mar. 01, 2024 | Mar. 01, 2024
Principal Amount | $ 1,600 | $ 2,000
Investments at cost | 1,587 | 1,983
Investments at fair value | 1,587 | 1,983
Intelepeer Holdings, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 138 | 139
Investments at fair value | $ 3,251 | $ 3,265
Number of shares (in shares) | 2,936,535 | 2,936,535
Engage3, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.50% | 4.50%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,680 | 3,678
Investments at fair value | $ 3,680 | $ 3,678
Engage3, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.50% | 4.50%
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,720 | 3,718
Investments at fair value | 3,720 | 3,718
Corvium, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 53 | 53
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 661,956 | 661,956
Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026
Principal Amount | $ 3,500 | $ 3,500
Investments at cost | 3,413 | 3,360
Investments at fair value | $ 3,413 | $ 3,360
Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026
Principal Amount | $ 3,500 | $ 3,500
Investments at cost | 3,463 | 3,460
Investments at fair value | 3,463 | 3,460
Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 16 | 16
Investments at fair value | $ 15 | $ 16
Number of shares (in shares) | 86,066 | 86,066
Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 4,719 | $ 4,943
Investments at cost | 4,658 | 4,943
Investments at fair value | $ 46 | $ 1,668
Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Dec. 31, 2025 | Dec. 31, 2025
Principal Amount | $ 2,217 | $ 2,500
Investments at cost | 2,182 | 2,467
Investments at fair value | 5 | 832
Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 48 | 47
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 77,690 | 77,690
PebblePost, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 91 | $ 92
Investments at fair value | $ 170 | $ 173
Number of shares (in shares) | 598,850 | 598,850
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 11.25% | 10.50%
Margin | 3.50% | 3.50%
Floor | 8.25% | 8.25%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Oct. 01, 2024 | Oct. 01, 2024
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,977 | 4,973
Investments at fair value | $ 4,977 | $ 4,973
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 11.25% | 10.50%
Margin | 3.50% | 3.50%
Floor | 8.25% | 8.25%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Oct. 01, 2024 | Oct. 01, 2024
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,977 | 4,973
Investments at fair value | 4,977 | 4,973
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 69 | 69
Investments at fair value | $ 206 | $ 209
Number of shares (in shares) | 145,483 | 145,483
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 11.25% | 10.50%
Margin | 3.50% | 3.50%
Floor | 8.25% | 8.25%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Oct. 01, 2024 | Oct. 01, 2024
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,481 | 2,478
Investments at fair value | $ 2,481 | $ 2,478
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 11.25% | 10.50%
Margin | 3.50% | 3.50%
Floor | 8.25% | 8.25%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Oct. 01, 2024 | Oct. 01, 2024
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,481 | 2,478
Investments at fair value | 2,481 | 2,478
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 176 | 176
Investments at fair value | $ 256 | $ 263
Number of shares (in shares) | 110,402 | 110,402
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, One [Member] |  |
Cash Rate | 12.57% | 12.07%
Margin | 4.72% | 7.90%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jun. 01, 2024 | Jun. 01, 2024
Principal Amount | $ 1,979 | $ 1,979
Investments at cost | 1,965 | 1,962
Investments at fair value | $ 1,965 | $ 1,962
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Two [Member] |  |
Cash Rate | 12.57% | 12.07%
Margin | 4.72% | 7.90%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jun. 01, 2024 | Jun. 01, 2024
Principal Amount | $ 1,979 | $ 1,979
Investments at cost | 1,966 | 1,963
Investments at fair value | $ 1,966 | $ 1,963
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Three [Member] |  |
Cash Rate | 12.57% | 12.07%
Margin | 4.72% | 7.90%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Nov. 01, 2025 | Nov. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,930 | 4,923
Investments at fair value | 4,930 | 4,923
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |
Investments at cost | 356 | 356
Investments at fair value | $ 356 | $ 356
Number of shares (in shares) | 32,831 | 32,831
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Four [Member] |  |
Cash Rate | 12.57% | 12.07%
Margin | 4.72% | 7.90%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,921 | 4,912
Investments at fair value | $ 4,921 | $ 4,912
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 12.50% | 11.75%
Margin | 4.75% | 4.75%
Floor | 8.50% | 8.50%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,601 | 3,597
Investments at fair value | $ 3,601 | $ 3,597
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 12.50% | 11.75%
Margin | 4.75% | 4.75%
Floor | 8.50% | 8.50%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,710 | 3,706
Investments at fair value | 3,710 | 3,706
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 40 | 40
Investments at fair value | $ 45 | $ 46
Number of shares (in shares) | 19,662 | 19,662
BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 167 |
Investments at fair value | $ 175 |
Number of shares (in shares) | 85,066 |
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.25% | 12.50%
Margin | 5.50% | 5.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027
Principal Amount | $ 7,000 | $ 7,000
Investments at cost | 6,663 | 6,619
Investments at fair value | $ 6,663 | $ 6,619
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.25% | 12.50%
Margin | 5.50% | 5.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027
Principal Amount | $ 3,500 | $ 3,500
Investments at cost | 3,452 | 3,448
Investments at fair value | $ 3,452 | 3,448
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost |  | 160
Investments at fair value |  | $ 170
Number of shares (in shares) |  | 80,544
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.25% | 12.50%
Margin | 5.50% | 5.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027
Principal Amount | $ 3,500 | $ 3,500
Investments at cost | 3,452 | 3,448
Investments at fair value | $ 3,452 | $ 3,448
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 13.50% |
Margin | 5.50% |
Floor | 9.50% |
Ceiling | 0.00% |
ETP | 3.00% |
Maturity Date | Apr. 01, 2028 |
Principal Amount | $ 2,750 |
Investments at cost | 2,704 |
Investments at fair value | 2,704 |
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate |  | 13.75%
Margin |  | 6.75%
Floor |  | 10.00%
Ceiling |  | 0.00%
ETP |  | 3.00%
Maturity Date |  | Jan. 01, 2025
Principal Amount |  | $ 5,000
Investments at cost |  | 4,966
Investments at fair value |  | $ 4,966
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate |  | 13.75%
Margin |  | 6.75%
Floor |  | 10.00%
Ceiling |  | 0.00%
ETP |  | 3.00%
Maturity Date |  | Jan. 01, 2025
Principal Amount |  | $ 5,000
Investments at cost |  | 4,966
Investments at fair value |  | 4,966
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 93 | 93
Investments at fair value | $ 64 | $ 64
Number of shares (in shares) | 20,000 | 20,000
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate |  | 13.75%
Margin |  | 6.75%
Floor |  | 10.00%
Ceiling |  | 0.00%
ETP |  | 3.00%
Maturity Date |  | Jan. 01, 2025
Principal Amount |  | $ 3,000
Investments at cost |  | 2,979
Investments at fair value |  | $ 2,979
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate |  | 13.75%
Margin |  | 6.75%
Floor |  | 10.00%
Ceiling |  | 0.00%
ETP |  | 3.00%
Maturity Date |  | Dec. 01, 2025
Principal Amount |  | $ 1,000
Investments at cost |  | 976
Investments at fair value |  | $ 976
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate |  | 13.75%
Margin |  | 6.75%
Floor |  | 10.00%
Ceiling |  | 0.00%
ETP |  | 3.00%
Maturity Date |  | Feb. 01, 2026
Principal Amount |  | $ 1,000
Investments at cost |  | 977
Investments at fair value |  | $ 977
Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,704 | 3,699
Investments at fair value | $ 3,585 | $ 3,699
Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,704 | 3,699
Investments at fair value | 3,585 | 3,699
Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 61 | 61
Investments at fair value | $ 72 | $ 74
Number of shares (in shares) | 201,537 | 201,537
Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 11.00% | 11.00%
Ceiling | 18.00% | 18.00%
ETP | 3.00% | 3.00%
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,802 | 4,798
Investments at fair value | $ 4,802 | $ 4,798
Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 11.00% | 11.00%
Ceiling | 18.00% | 18.00%
ETP | 3.00% | 3.00%
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,953 | 4,948
Investments at fair value | 4,953 | 4,948
Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 7 | 6
Investments at fair value | $ 1 | $ 6
Number of shares (in shares) | 86,300 | 86,300
Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Convertible Debt Securities [Member] |  |
Cash Rate | 15.00% |
Maturity Date | Sep. 10, 2024 |
Principal Amount | $ 500 |
Investments at cost | 500 |
Investments at fair value | $ 500 |
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 12.25% | 11.75%
Margin | 4.25% | 4.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 4.25% | 4.25%
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028
Principal Amount | $ 10,000 | $ 10,000
Investments at cost | 9,880 | 9,872
Investments at fair value | $ 9,880 | $ 9,872
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 12.25% | 11.75%
Margin | 4.25% | 4.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 4.25% | 4.25%
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028
Principal Amount | $ 15,000 | $ 15,000
Investments at cost | 14,819 | 14,808
Investments at fair value | 14,819 | 14,808
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 126 | 126
Investments at fair value | $ 0 | $ 125
Number of shares (in shares) | 463,915 | 463,915
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 12.25% | 11.75%
Margin | 4.25% | 4.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 4.25% | 4.25%
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028
Principal Amount | $ 6,000 | $ 6,000
Investments at cost | 5,928 | 5,923
Investments at fair value | $ 5,928 | $ 5,923
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 12.25% | 11.75%
Margin | 4.25% | 4.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 4.25% | 4.25%
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028
Principal Amount | $ 6,000 | $ 6,000
Investments at cost | 5,928 | 5,923
Investments at fair value | $ 5,928 | $ 5,923
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 12.25% | 11.75%
Margin | 4.25% | 4.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 4.25% | 4.25%
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028
Principal Amount | $ 4,000 | $ 4,000
Investments at cost | 3,952 | 3,949
Investments at fair value | $ 3,952 | $ 3,949
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |
Cash Rate | 12.25% | 11.75%
Margin | 4.25% | 4.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 4.25% | 4.25%
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028
Principal Amount | $ 4,000 | $ 4,000
Investments at cost | 3,952 | 3,949
Investments at fair value | $ 3,952 | $ 3,949
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.25% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 8.00% | 8.00%
Maturity Date | Jun. 01, 2025 | Jun. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,478 | 2,476
Investments at fair value | $ 2,478 | $ 2,476
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.25% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 8.00% | 8.00%
Maturity Date | Jun. 01, 2025 | Jun. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,478 | 2,476
Investments at fair value | 2,478 | 2,476
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 98 | 98
Investments at fair value | $ 120 | $ 123
Number of shares (in shares) | 605,313 | 605,313
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.25% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 8.00% | 8.00%
Maturity Date | Jun. 01, 2025 | Jun. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,478 | 2,476
Investments at fair value | $ 2,478 | $ 2,476
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 14.25% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 8.00% | 8.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,459 | 2,453
Investments at fair value | $ 2,459 | $ 2,453
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 14.25% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 8.00% | 8.00%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,458 | 2,455
Investments at fair value | 2,458 | 2,455
Medsphere Systems Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 60 |
Investments at fair value | $ 354 |
Number of shares (in shares) | 7,097,792 |
Medsphere Systems Corporation [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost |  | 60
Investments at fair value |  | $ 359
Number of shares (in shares) |  | 7,097,792
Embody, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate |  | 14.00%
Margin |  | 6.50%
Floor |  | 9.75%
Ceiling |  | 0.00%
ETP |  | 28.00%
Maturity Date |  | Aug. 01, 2026
Principal Amount |  | $ 2,500
Investments at cost |  | 2,482
Investments at fair value |  | 2,482
Aterian, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | $ 195 | 195
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 76,923 | 76,923
Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025
Principal Amount | $ 4,500 | $ 5,000
Investments at cost | 4,371 | 4,857
Investments at fair value | $ 4,352 | $ 4,857
Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025
Principal Amount | $ 2,250 | $ 2,500
Investments at cost | 2,187 | 2,430
Investments at fair value | 2,177 | 2,430
Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 366 | 366
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 47,452 | 47,452
VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 53 | $ 53
Investments at fair value | $ 1 | $ 1
Number of shares (in shares) | 408 | 408
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Oct. 01, 2024 | Oct. 01, 2024
Principal Amount | $ 2,771 | $ 3,208
Investments at cost | 2,715 | 3,143
Investments at fair value | $ 2,715 | $ 3,143
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Jun. 01, 2025 | Jun. 01, 2025
Principal Amount | $ 1,000 | $ 1,000
Investments at cost | 977 | 974
Investments at fair value | 977 | 974
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 124 | 124
Investments at fair value | $ 51 | $ 113
Number of shares (in shares) | 317,647 | 317,647
F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate |  | 13.25%
Margin |  | 6.25%
Floor |  | 9.50%
Ceiling |  | 0.00%
ETP |  | 4.00%
Maturity Date |  | Apr. 01, 2025
Principal Amount |  | $ 2,500
Investments at cost |  | 2,476
Investments at fair value |  | $ 2,476
F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate |  | 13.25%
Margin |  | 6.25%
Floor |  | 9.50%
Ceiling |  | 0.00%
ETP |  | 4.00%
Maturity Date |  | Jul. 01, 2025
Principal Amount |  | $ 2,500
Investments at cost |  | 2,473
Investments at fair value |  | 2,473
F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost |  | 35
Investments at fair value |  | $ 0
Number of shares (in shares) |  | 21,120
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 1.85% | 1.85%
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,951 | 4,951
Investments at fair value | $ 3,467 | $ 3,834
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.25% | 13.75%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 1.85% | 1.85%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,474 | 2,474
Investments at fair value | 1,733 | 1,916
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 26 | 26
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 2,672 | 10,690
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 15.00% | 14.50%
Margin | 7.00% | 7.00%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Sep. 01, 2025 | Sep. 01, 2025
Principal Amount | $ 7,500 | $ 7,500
Investments at cost | 7,383 | 7,371
Investments at fair value | $ 7,245 | $ 7,371
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 15.00% | 14.50%
Margin | 7.00% | 7.00%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Sep. 01, 2025 | Sep. 01, 2025
Principal Amount | $ 7,500 | $ 7,500
Investments at cost | 7,383 | 7,371
Investments at fair value | 7,245 | 7,371
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 490 | 488
Investments at fair value | $ 1 | $ 1,061
Number of shares (in shares) | 204,195 | 204,832
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 15.00% | 14.50%
Margin | 7.00% | 7.00%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Sep. 01, 2025 | Sep. 01, 2025
Principal Amount | $ 7,500 | $ 7,500
Investments at cost | 7,383 | 7,371
Investments at fair value | $ 7,245 | $ 7,371
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 15.00% | 14.50%
Margin | 7.00% | 7.00%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Jul. 01, 2026 | Jul. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,912 | 4,903
Investments at fair value | $ 4,820 | $ 4,903
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 15.00% | 14.50%
Margin | 7.00% | 7.00%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Jul. 01, 2026 | Jul. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,912 | 4,903
Investments at fair value | 4,820 | 4,903
Imunon, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 66 | 66
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 19,671 | 16,502
Caastle, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 68 | $ 68
Investments at fair value | $ 1,057 | $ 1,069
Number of shares (in shares) | 268,591 | 268,591
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 8.75% | 8.75%
Ceiling | 0.00% | 0.00%
ETP | 6.00% | 6.00%
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026
Principal Amount | $ 5,000 | $ 2,500
Investments at cost | 4,940 | 2,466
Investments at fair value | $ 4,940 | $ 2,466
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 8.75% | 8.75%
Ceiling | 0.00% | 0.00%
ETP | 6.00% | 6.00%
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026
Principal Amount | $ 2,500 | $ 5,000
Investments at cost | 2,470 | 4,932
Investments at fair value | 2,470 | 4,932
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 144 | 148
Investments at fair value | $ 173 | $ 179
Number of shares (in shares) | 775,000 | 775,000
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 10,000 | $ 10,000
Investments at cost | 9,843 | 9,826
Investments at fair value | $ 9,843 | $ 9,826
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 10,000 | $ 10,000
Investments at cost | 9,843 | 9,826
Investments at fair value | 9,843 | 9,826
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 275 | 273
Investments at fair value | $ 287 | $ 296
Number of shares (in shares) | 639,918 | 639,918
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,921 | 4,913
Investments at fair value | $ 4,921 | $ 4,913
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,921 | 4,913
Investments at fair value | $ 4,921 | $ 4,913
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,951 | 4,946
Investments at fair value | $ 4,759 | $ 4,946
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,476 | 2,473
Investments at fair value | 2,380 | 2,473
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 67 | 67
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 39,774 | 39,774
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jan. 01, 2026 | Jan. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,953 | 4,947
Investments at fair value | $ 4,761 | $ 4,947
IMV Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Jan. 01, 2026 | Jan. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,953 | 4,947
Investments at fair value | 4,761 | 4,947
Lumithera, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] |  |
Investments at cost | 1,200 | 1,200
Investments at fair value | 1,100 | 1,100
Lumithera, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |
Investments at cost | 2,000 | 2,000
Investments at fair value | $ 1,700 | $ 1,700
Number of shares (in shares) | 392,651 | 392,651
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.00% | 12.50%
Margin | 5.00% | 5.00%
Floor | 5.00% | 5.00%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027
Principal Amount | $ 2,000 | $ 2,000
Investments at cost | 1,165 | 1,082
Investments at fair value | $ 1,165 | $ 1,082
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.00% | 12.50%
Margin | 5.00% | 5.00%
Floor | 5.00% | 5.00%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027
Principal Amount | $ 3,000 | $ 3,000
Investments at cost | 1,748 | 1,623
Investments at fair value | 1,748 | 1,623
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 2,942 | 2,947
Investments at fair value | $ 2,674 | $ 2,947
Number of shares (in shares) | 1,312,500 | 1,312,500
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 11.50% | 11.00%
Margin | 3.50% | 3.50%
Floor | 10.50% | 10.50%
Ceiling | 0.00% | 0.00%
ETP | 7.78% | 7.78%
Maturity Date | Feb. 01, 2028 | Feb. 01, 2028
Principal Amount | $ 2,813 | $ 2,813
Investments at cost | 2,813 | 2,813
Investments at fair value | $ 2,813 | $ 2,813
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 11.50% | 11.00%
Margin | 3.50% | 3.50%
Floor | 10.50% | 10.50%
Ceiling | 0.00% | 0.00%
ETP | 7.78% | 7.78%
Maturity Date | Feb. 01, 2028 | Feb. 01, 2028
Principal Amount | $ 2,813 | $ 2,813
Investments at cost | 2,813 | 2,813
Investments at fair value | $ 2,813 | $ 2,813
CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 15.25% | 14.75%
Margin | 7.25% | 7.25%
Floor | 10.50% | 10.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 3,500 | $ 3,500
Investments at cost | 3,464 | 3,461
Investments at fair value | 3,464 | 3,461
CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 22 | 20
Investments at fair value | $ 0 | $ 61
Number of shares (in shares) | 17,605 | 17,605
KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 12.75% | 12.25%
Margin | 4.75% | 4.75%
Floor | 8.50% | 8.50%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | May 01, 2027 | May 01, 2027
Principal Amount | $ 6,250 | $ 6,250
Investments at cost | 6,082 | 6,077
Investments at fair value | $ 6,082 | $ 6,077
KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 12.75% | 12.25%
Margin | 4.75% | 4.75%
Floor | 8.50% | 8.50%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | May 01, 2027 | May 01, 2027
Principal Amount | $ 6,250 | $ 6,250
Investments at cost | 6,182 | 6,177
Investments at fair value | 6,182 | 6,177
KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 50 | 51
Investments at fair value | $ 56 | $ 60
Number of shares (in shares) | 48,076 | 48,077
ZetrOZ, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] |  |
Investments at cost | $ 0 | $ 0
Investments at fair value | $ 200 | $ 200
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025
Principal Amount | $ 2,333 | $ 2,500
Investments at cost | 2,318 | 2,482
Investments at fair value | $ 2,318 | $ 2,482
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025
Principal Amount | $ 2,333 | $ 2,500
Investments at cost | 2,318 | 2,482
Investments at fair value | 2,318 | 2,482
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 30 | 30
Investments at fair value | $ 124 | $ 125
Number of shares (in shares) | 46,745 | 46,745
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 221 | $ 221
Investments at fair value | $ 221 | $ 226
Number of shares (in shares) | 7,972,222 | 7,972,222
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, One [Member] |  |
Cash Rate | 12.67% | 12.17%
Margin | 8.00% | 8.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 10.36% | 10.36%
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025
Principal Amount | $ 3,960 | $ 3,960
Investments at cost | 3,904 | 3,898
Investments at fair value | $ 3,904 | $ 3,898
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Two [Member] |  |
Cash Rate | 12.67% | 12.17%
Margin | 8.00% | 8.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 10.36% | 10.36%
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025
Principal Amount | $ 3,960 | $ 3,960
Investments at cost | 3,904 | 3,898
Investments at fair value | 3,904 | 3,898
Mustang Bio, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 141 | 146
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 252,161 | 252,161
LiquiGlide, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | $ 39 | $ 39
Investments at fair value | $ 53 | $ 55
Number of shares (in shares) | 61,359 | 61,539
Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.25% | 12.75%
Margin | 5.25% | 5.25%
Floor | 8.50% | 8.50%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,707 | 3,630
Investments at fair value | $ 3,707 | $ 3,630
Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.25% | 12.75%
Margin | 5.25% | 5.25%
Floor | 8.50% | 8.50%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,472 | 2,469
Investments at fair value | 2,472 | 2,469
Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 64 | 64
Investments at fair value | $ 159 | $ 162
Number of shares (in shares) | 103,679 | 103,679
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.75% | 2.75%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 5,000 | $ 2,500
Investments at cost | 4,935 | 2,463
Investments at fair value | $ 4,935 | $ 2,463
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.75% | 2.75%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 2,500 | $ 5,000
Investments at cost | 2,467 | 4,927
Investments at fair value | 2,467 | 4,927
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 214 | 214
Investments at fair value | $ 354 | $ 361
Number of shares (in shares) | 681 | 681
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.75% | 2.75%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,932 | 4,924
Investments at fair value | $ 4,932 | $ 4,924
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.75% | 2.75%
Maturity Date | May 01, 2026 | May 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,466 | 2,462
Investments at fair value | $ 2,466 | $ 2,462
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 11.75% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.75% | 2.75%
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,909 | 4,900
Investments at fair value | $ 4,909 | $ 4,900
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |
Cash Rate | 13.50% | 13.00%
Margin | 5.50% | 5.50%
Floor | 11.75% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.75% | 2.75%
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,454 | 2,450
Investments at fair value | $ 2,454 | $ 2,450
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.50% | 14.00%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Mar. 01, 2026 | Mar. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,953 | 4,947
Investments at fair value | $ 4,953 | $ 4,947
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.50% | 14.00%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Mar. 01, 2026 | Mar. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,477 | 2,474
Investments at fair value | 2,477 | 2,474
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 35 | 34
Investments at fair value | $ 40 | $ 41
Number of shares (in shares) | 101,308 | 101,308
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 3.75% | 3.75%
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026
Principal Amount | $ 10,000 | $ 10,000
Investments at cost | 9,714 | 9,701
Investments at fair value | $ 9,714 | $ 9,701
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 3.75% | 3.75%
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,702 | 3,697
Investments at fair value | 3,702 | 3,697
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 160 | 160
Investments at fair value | $ 937 | $ 3,024
Number of shares (in shares) | 299,848 | 299,848
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 3.75% | 3.75%
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,702 | 3,697
Investments at fair value | $ 3,702 | $ 3,697
Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.50% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Jan. 01, 2026 | Jan. 01, 2026
Principal Amount | $ 3,246 | $ 3,210
Investments at cost | 3,162 | 3,151
Investments at fair value | $ 0 | $ 0
Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.50% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Jan. 01, 2026 | Jan. 01, 2026
Principal Amount | $ 2,963 | $ 2,963
Investments at cost | 2,886 | 2,886
Investments at fair value | 0 | 0
Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost |  | 103
Investments at fair value |  | $ 0
Number of shares (in shares) |  | 553,710
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 401 | $ 399
Investments at fair value | $ 128 | $ 648
Number of shares (in shares) | 254,609 | 203,017
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, One [Member] |  |
Cash Rate | 13.17% | 12.67%
Margin | 8.50% | 8.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024
Principal Amount | $ 4,667 | $ 4,667
Investments at cost | 4,606 | 4,597
Investments at fair value | $ 4,606 | $ 4,597
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Two [Member] |  |
Cash Rate | 13.17% | 12.67%
Margin | 8.50% | 8.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024
Principal Amount | $ 4,667 | $ 4,667
Investments at cost | 4,606 | 4,597
Investments at fair value | $ 4,606 | $ 4,597
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Three [Member] |  |
Cash Rate | 13.17% | 12.67%
Margin | 8.50% | 8.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024
Principal Amount | $ 2,333 | $ 2,333
Investments at cost | 2,287 | 2,280
Investments at fair value | $ 2,287 | $ 2,280
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Four [Member] |  |
Cash Rate | 13.17% | 12.67%
Margin | 8.50% | 8.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024
Principal Amount | $ 2,333 | $ 2,333
Investments at cost | 2,287 | 2,280
Investments at fair value | $ 2,287 | $ 2,280
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Five [Member] |  |
Cash Rate | 13.17% | 12.67%
Margin | 8.50% | 8.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024
Principal Amount | $ 2,333 | $ 2,333
Investments at cost | 2,282 | 2,274
Investments at fair value | $ 2,282 | $ 2,274
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, LIBOR Index, Six [Member] |  |
Cash Rate | 13.17% | 12.67%
Margin | 8.50% | 8.50%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 5.50% | 5.50%
Maturity Date | Dec. 01, 2024 | Dec. 01, 2024
Principal Amount | $ 2,333 | $ 2,333
Investments at cost | 2,282 | 2,274
Investments at fair value | $ 2,282 | $ 2,274
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Jun. 01, 2025 | Jun. 01, 2025
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,706 | 3,697
Investments at fair value | $ 3,706 | $ 3,697
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Jun. 01, 2025 | Jun. 01, 2025
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,720 | 3,717
Investments at fair value | 3,720 | 3,717
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 118 | 126
Investments at fair value | $ 259 | $ 268
Number of shares (in shares) | 34,604 | 35,906
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 7,500 | $ 7,500
Investments at cost | 7,431 | 7,424
Investments at fair value | $ 7,431 | $ 7,424
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,715 | 3,712
Investments at fair value | $ 3,715 | $ 3,712
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 2.50% | 2.50%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 3,750 | $ 3,750
Investments at cost | 3,715 | 3,712
Investments at fair value | 3,715 | 3,712
Getaround, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |
Investments at cost | 253 | 253
Investments at fair value | $ 25 | $ 57
Number of shares (in shares) | 87,082 | 87,082
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,961 | 4,954
Investments at fair value | $ 4,961 | $ 4,954
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.75% | 14.25%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,480 | 2,477
Investments at fair value | 2,480 | 2,477
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 29 | 29
Investments at fair value | $ 36 | $ 37
Number of shares (in shares) | 143 | 143
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.75% | 13.00%
Margin | 6.00% | 6.00%
Floor | 9.25% | 9.25%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Nov. 01, 2026 | Jul. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,411 | 2,396
Investments at fair value | $ 2,411 | $ 2,396
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.75% | 13.00%
Margin | 6.00% | 6.00%
Floor | 12.25% | 12.25%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026
Principal Amount | $ 1,250 | $ 1,250
Investments at cost | 1,232 | 1,231
Investments at fair value | 1,232 | 1,231
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 43 | 40
Investments at fair value | $ 46 | $ 44
Number of shares (in shares) | 85,543 | 80,197
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.75% |
Margin | 6.00% |
Floor | 12.25% |
Ceiling | 0.00% |
ETP | 3.00% |
Maturity Date | Apr. 01, 2027 |
Principal Amount | $ 1,000 |
Investments at cost | 984 |
Investments at fair value | 984 |
Rocket Pharmaceuticals Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 17 | $ 17
Investments at fair value | $ 2 | $ 14
Number of shares (in shares) | 7,051 | 7,051
SnagAJob.com, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |
Investments at cost | $ 9 | $ 8
Investments at fair value | $ 83 | $ 83
Number of shares (in shares) | 82,974 | 82,974
Lyrical Foods, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 10.50% | 10.00%
Margin | 2.50% | 6.75%
Floor | 8.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 0.00% | 0.00%
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027
Principal Amount | $ 2,598 | $ 2,500
Investments at cost | 2,586 | 2,588
Investments at fair value | $ 2,330 | $ 2,279
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.25% | 2.00%
Maturity Date | Oct. 31, 2023 | Dec. 30, 2022
Principal Amount | $ 5,169 | $ 5,000
Investments at cost | 5,121 | 4,943
Investments at fair value | $ 4,883 | $ 4,715
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.25% | 2.00%
Maturity Date | Oct. 31, 2023 | Dec. 30, 2022
Principal Amount | $ 2,067 | $ 2,000
Investments at cost | 2,050 | 1,981
Investments at fair value | 1,955 | 1,890
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 197 | 197
Investments at fair value | $ 17 | $ 17
Number of shares (in shares) | 1,261,253 | 1,261,253
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.25% | 2.00%
Maturity Date | Oct. 31, 2023 | Dec. 30, 2022
Principal Amount | $ 2,584 | $ 2,500
Investments at cost | 2,564 | 2,477
Investments at fair value | $ 2,446 | $ 2,363
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.25% | 2.00%
Maturity Date | Oct. 31, 2023 | Dec. 30, 2022
Principal Amount | $ 3,101 | $ 3,000
Investments at cost | 3,076 | 2,971
Investments at fair value | $ 2,934 | $ 2,835
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.25% | 2.00%
Maturity Date | Oct. 31, 2023 | Dec. 30, 2022
Principal Amount | $ 2,584 | $ 2,500
Investments at cost | 2,548 | 2,459
Investments at fair value | $ 2,430 | $ 2,345
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.25% | 2.00%
Maturity Date | Oct. 31, 2023 | Dec. 30, 2022
Principal Amount | $ 2,584 | $ 2,500
Investments at cost | 2,548 | 2,459
Investments at fair value | $ 2,430 | $ 2,345
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.25% | 2.00%
Maturity Date | Oct. 31, 2023 | Dec. 30, 2022
Principal Amount | $ 5,169 | $ 5,000
Investments at cost | 5,093 | 4,914
Investments at fair value | $ 4,859 | $ 4,688
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] |  |
Cash Rate | 13.50% | 12.75%
Margin | 5.75% | 5.75%
Floor | 9.00% | 9.00%
Ceiling | 0.00% | 0.00%
ETP | 5.25% | 2.00%
Maturity Date | Oct. 31, 2023 | Dec. 30, 2022
Principal Amount | $ 2,584 | $ 2,500
Investments at cost | 2,545 | 2,456
Investments at fair value | $ 2,428 | $ 2,342
Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,355 | 2,347
Investments at fair value | 2,355 | 2,347
Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 104 | 104
Investments at fair value | $ 104 | $ 104
Number of shares (in shares) | 6,600 | 6,600
vTv Therapeutics Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | $ 44 | $ 44
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 95,293 | 95,293
Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] |  |
Investments at cost | $ 8 | $ 8
Investments at fair value | $ 27 | $ 27
Number of shares (in shares) | 22,313 | 22,313
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 15.00% | 14.25%
Margin | 7.25% | 7.25%
Floor | 10.50% | 10.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Mar. 01, 2025 | Mar. 01, 2025
Principal Amount | $ 2,300 | $ 2,700
Investments at cost | 2,277 | 2,673
Investments at fair value | $ 2,277 | $ 2,673
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 15.00% | 14.25%
Margin | 7.25% | 7.25%
Floor | 10.50% | 10.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Mar. 01, 2025 | Mar. 01, 2025
Principal Amount | $ 2,300 | $ 2,700
Investments at cost | 2,277 | 2,673
Investments at fair value | 2,277 | 2,673
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 57 | 57
Investments at fair value | $ 427 | $ 429
Number of shares (in shares) | 553,778 | 553,778
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 15.00% | 14.25%
Margin | 7.25% | 7.25%
Floor | 10.50% | 10.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Sep. 01, 2025 | Sep. 01, 2025
Principal Amount | $ 2,900 | $ 3,000
Investments at cost | 2,870 | 2,967
Investments at fair value | $ 2,870 | 2,967
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.00% |
Margin | 5.00% |
Floor | 12.00% |
Ceiling | 0.00% |
ETP | 3.00% |
Maturity Date | Mar. 01, 2027 |
Principal Amount | $ 10,000 |
Investments at cost | 9,733 |
Investments at fair value | $ 9,733 |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.00% |
Margin | 5.00% |
Floor | 12.00% |
Ceiling | 0.00% |
ETP | 3.00% |
Maturity Date | Mar. 01, 2027 |
Principal Amount | $ 5,000 |
Investments at cost | 4,928 |
Investments at fair value | 4,928 |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 116 |
Investments at fair value | $ 116 |
Number of shares (in shares) | 84,037 |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.00% |
Margin | 5.00% |
Floor | 12.00% |
Ceiling | 0.00% |
ETP | 3.00% |
Maturity Date | Mar. 01, 2027 |
Principal Amount | $ 5,000 |
Investments at cost | 4,928 |
Investments at fair value | 4,928 |
Xeris Pharmaceuticals, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 72 | 72
Investments at fair value | $ 9 | $ 3
Number of shares (in shares) | 126,000 | 126,000
Branded Online, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock [Member] |  |
Investments at cost | $ 1,075 | $ 1,079
Investments at fair value | $ 14 | $ 83
Number of shares (in shares) | 5,398 | 108,004
Quip NYC Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 325 | $ 325
Investments at fair value | $ 532 | $ 534
Number of shares (in shares) | 6,191 | 6,191
AccuVein Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | $ 24 | $ 24
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 1,175 | 1,175
Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 17.43% | 16.93%
Margin | 9.43% | 9.43%
Floor | 12.68% | 12.68%
Ceiling | 0.00% | 0.00%
ETP | 50.43% | 50.43%
Maturity Date | Dec. 31, 2022 | Dec. 31, 2022
Principal Amount | $ 3,284 | $ 3,295
Investments at cost | 3,284 | 3,295
Investments at fair value | 2,750 | 3,295
Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 46 | 46
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 82,967 | 82,967
Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred and Common Stock [Member] |  |
Investments at cost | $ 229 |
Investments at fair value | $ 0 |
Number of shares (in shares) | 72,638,663 |
Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |
Investments at cost |  | $ 230
Investments at fair value |  | $ 0
Number of shares (in shares) |  | 72,638,663
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 15.75% | 15.25%
Margin | 7.75% | 7.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 0.00% | 0.00%
Maturity Date | May 01, 2027 | Jul. 01, 2025
Principal Amount | $ 1,065 | $ 2,500
Investments at cost | 1,041 | 2,473
Investments at fair value | $ 1,041 | $ 2,473
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 15.75% | 15.25%
Margin | 7.75% | 7.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 0.00% | 0.00%
Maturity Date | May 01, 2027 | Jul. 01, 2025
Principal Amount | $ 533 | $ 1,250
Investments at cost | 520 | 1,236
Investments at fair value | 520 | 1,236
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 32 | 32
Investments at fair value | $ 111 | $ 22
Number of shares (in shares) | 171,081 | 171,081
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 15.75% | 15.25%
Margin | 7.75% | 7.75%
Floor | 11.00% | 11.00%
Ceiling | 0.00% | 0.00%
ETP | 0.00% | 0.00%
Maturity Date | May 01, 2027 | Jul. 01, 2025
Principal Amount | $ 533 | $ 1,250
Investments at cost | 521 | 1,236
Investments at fair value | 521 | 1,236
Aerin Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 66 | 64
Investments at fair value | $ 1,196 | $ 1,200
Number of shares (in shares) | 1,818,183 | 1,818,183
Lotame Solutions, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 19 | $ 22
Investments at fair value | $ 53 | $ 312
Number of shares (in shares) | 71,305 | 288,115
Lotame Solutions, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] |  |
Investments at cost | $ 5 |
Investments at fair value | $ 193 |
Number of shares (in shares) | 66,127 |
Updater, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | $ 34 | $ 34
Investments at fair value | $ 42 | $ 42
Number of shares (in shares) | 108,333 | 108,333
Reputation Institute, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 15.00% | 14.25%
Margin | 7.25% | 7.25%
Floor | 10.50% | 10.50%
Ceiling | 0.00% | 0.00%
ETP | 3.00% | 3.00%
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025
Principal Amount | $ 4,833 | $ 5,000
Investments at cost | 4,772 | 4,932
Investments at fair value | 4,772 | 4,932
Reputation Institute, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 61 | 56
Investments at fair value | $ 46 | $ 39
Number of shares (in shares) | 3,731 | 3,731
CPG Beyond, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 242 | $ 242
Investments at fair value | $ 903 | $ 909
Number of shares (in shares) | 500,000 | 500,000
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,940 | 4,870
Investments at fair value | $ 4,940 | $ 4,870
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,940 | 4,933
Investments at fair value | 4,940 | 4,933
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 123 | 123
Investments at fair value | $ 135 | $ 133
Number of shares (in shares) | 309,208 | 309,208
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,875 | 4,933
Investments at fair value | $ 4,875 | $ 4,933
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 13.75% | 13.25%
Margin | 5.75% | 5.75%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Aug. 01, 2026 | Aug. 01, 2026
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,940 | 4,933
Investments at fair value | 4,940 | $ 4,933
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate |  | 12.75%
Margin |  | 5.75%
Floor |  | 9.00%
Ceiling |  | 0.00%
ETP |  | 7.00%
Maturity Date |  | Nov. 01, 2024
Principal Amount |  | $ 2,500
Investments at cost |  | 2,475
Investments at fair value |  | $ 2,475
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate |  | 12.75%
Margin |  | 5.75%
Floor |  | 9.00%
Ceiling |  | 0.00%
ETP |  | 7.00%
Maturity Date |  | Nov. 01, 2024
Principal Amount |  | $ 2,500
Investments at cost |  | 2,489
Investments at fair value |  | 2,489
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 86 | 84
Investments at fair value | $ 1,862 | $ 1,864
Number of shares (in shares) | 12,153 | 12,153
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate |  | 12.75%
Margin |  | 5.75%
Floor |  | 9.00%
Ceiling |  | 0.00%
ETP |  | 7.00%
Maturity Date |  | Nov. 01, 2024
Principal Amount |  | $ 2,500
Investments at cost |  | 2,473
Investments at fair value |  | 2,473
Silk, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost |  | 234
Investments at fair value |  | $ 407
Number of shares (in shares) |  | 442,110
Silk, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost | $ 234 |
Investments at fair value | $ 399 |
Number of shares (in shares) | 442,110 |
Global Worldwide LLC [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 75 | $ 75
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 245,810 | 245,810
Cadrenal Therapeutics, Inc. [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |
Investments at fair value | $ 846 | $ 0
Cadrenal Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Common Stock [Member] |  |
Investments at cost | 0 |
Investments at fair value | $ 846 |
Number of shares (in shares) | 600,000 |
Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 15.00% | 14.50%
Margin | 7.00% | 7.00%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 1.00% | 1.00%
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025
Principal Amount | $ 5,000 | $ 5,000
Investments at cost | 4,969 | 4,966
Investments at fair value | $ 4,969 | $ 4,966
Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 15.00% | 14.50%
Margin | 7.00% | 7.00%
Floor | 10.25% | 10.25%
Ceiling | 0.00% | 0.00%
ETP | 1.00% | 1.00%
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,483 | 2,481
Investments at fair value | 2,483 | 2,481
Rocket Lawyer Incorporated [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 92 | 92
Investments at fair value | $ 352 | $ 357
Number of shares (in shares) | 261,721 | 261,721
Skillshare, Inc [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 162 | $ 162
Investments at fair value | $ 1,231 | $ 802
Number of shares (in shares) | 139,074 | 139,074
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.25% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Feb. 01, 2025 | Feb. 01, 2025
Principal Amount | $ 3,208 | $ 3,500
Investments at cost | 3,183 | 3,472
Investments at fair value | $ 3,183 | $ 3,472
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.25% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Feb. 01, 2025 | Dec. 01, 2025
Principal Amount | $ 3,208 | $ 2,500
Investments at cost | 3,183 | 2,472
Investments at fair value | 3,183 | 2,472
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 64 | 64
Investments at fair value | $ 140 | $ 83
Number of shares (in shares) | 682 | 682
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.25% | 13.50%
Margin | 6.50% | 6.50%
Floor | 9.75% | 9.75%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Dec. 01, 2025 | Dec. 01, 2025
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,475 | 2,472
Investments at fair value | $ 2,475 | $ 2,472
Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 14.25% |
Margin | 6.50% |
Floor | 9.75% |
Ceiling | 0.00% |
ETP | 4.00% |
Maturity Date | Dec. 01, 2025 |
Principal Amount | $ 2,500 |
Investments at cost | 2,475 |
Investments at fair value | $ 2,475 |
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024
Principal Amount | $ 2,833 | $ 3,333
Investments at cost | 2,793 | 3,286
Investments at fair value | $ 2,793 | $ 3,286
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024
Principal Amount | $ 2,833 | $ 3,333
Investments at cost | 2,793 | 3,286
Investments at fair value | 2,793 | 3,286
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 364 | 364
Investments at fair value | $ 237 | $ 243
Number of shares (in shares) | 344,102 | 344,102
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024
Principal Amount | $ 1,417 | $ 1,667
Investments at cost | 1,395 | 1,641
Investments at fair value | $ 1,395 | $ 1,641
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024
Principal Amount | $ 1,417 | $ 1,667
Investments at cost | 1,395 | 1,641
Investments at fair value | $ 1,395 | $ 1,641
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |
Cash Rate | 14.00% | 13.25%
Margin | 6.25% | 6.25%
Floor | 9.50% | 9.50%
Ceiling | 0.00% | 0.00%
ETP | 4.00% | 4.00%
Maturity Date | Sep. 01, 2024 | Sep. 01, 2024
Principal Amount | $ 1,417 | $ 1,667
Investments at cost | 1,371 | 1,613
Investments at fair value | 1,371 | 1,613
CVRx, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 76 | 76
Investments at fair value | $ 72 | $ 394
Number of shares (in shares) | 47,410 | 47,410
Halio, Inc [Member] | Power Management Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 1,585 | $ 1,585
Investments at fair value | $ 2,808 | $ 2,610
Number of shares (in shares) | 5,002,574 | 5,002,574
Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost | $ 57 | $ 56
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 6,081 | 6,081
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |
Cash Rate | 14.50% | 13.75%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Mar. 01, 2026 | Mar. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,488 | 2,421
Investments at fair value | $ 2,488 | $ 2,421
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |
Cash Rate | 14.50% | 13.75%
Margin | 6.75% | 6.75%
Floor | 10.00% | 10.00%
Ceiling | 0.00% | 0.00%
ETP | 5.00% | 5.00%
Maturity Date | Mar. 01, 2026 | Mar. 01, 2026
Principal Amount | $ 2,500 | $ 2,500
Investments at cost | 2,488 | 2,487
Investments at fair value | 2,488 | 2,487
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | 21 | 21
Investments at fair value | $ 67 | $ 69
Number of shares (in shares) | 77,828 | 77,828
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |
Cash Rate | 14.50% |
Margin | 6.75% |
Floor | 10.00% |
Ceiling | 0.00% |
ETP | 3.00% |
Maturity Date | Mar. 01, 2027 |
Principal Amount | $ 2,500 |
Investments at cost | 2,467 |
Investments at fair value | $ 2,467 |
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |
Cash Rate | 14.50% |
Margin | 6.75% |
Floor | 10.00% |
Ceiling | 0.00% |
ETP | 3.00% |
Maturity Date | Mar. 01, 2027 |
Principal Amount | $ 2,500 |
Investments at cost | 2,467 |
Investments at fair value | 2,467 |
E La Carte, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |
Investments at cost | 60 | $ 60
Investments at fair value | $ 0 | $ 3
Number of shares (in shares) | 147,361 | 147,361
Revinate Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 44 | $ 46
Investments at fair value | $ 97 | $ 99
Number of shares (in shares) | 682,034 | 682,034
Riv Data Corp [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 12 | $ 12
Investments at fair value | $ 296 | $ 296
Number of shares (in shares) | 321,428 | 321,428
SIGNiX, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 225 | $ 225
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 186,235 | 186,235
Skyword, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |
Investments at cost |  | $ 48
Investments at fair value |  | $ 1
Number of shares (in shares) |  | 301,055
Topia Mobility, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 138 | $ 138
Investments at fair value | $ 0 | $ 0
Number of shares (in shares) | 3,049,607 | 3,049,607
xAd, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |
Investments at cost | $ 177 | $ 177
Investments at fair value | $ 11 | $ 12
Number of shares (in shares) | 4,343,348 | 4,343,348

X
- Definition The ceiling rate of the investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedCeilingRate
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The end of term payment rate (ETP) on investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_HealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DataStorageSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_InternetAndMediaSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_PowerManagementSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SemiconductorSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareHealthcareInformationAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CorinthMedtechIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_ConvertibleDebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CsaMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_Engage3LLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CorviumIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SecureTransfusionServicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GroundspeedAnalyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmbodyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AterianIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_FstarTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImvIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ZetrozIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PdsBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InteriorDefineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketPharmaceuticalsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VtvTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrandedOnlineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredAndCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ReputationInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CpgBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CvrxIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HalioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RivDataCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkywordIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |